Based on this evidence, the aim of this study was to compare levels of ghrelin, leptin, and testosterone hormones of MS patients with healthy subjects, and assess the relationship between levels of peptide hormone and sex hormone in MS patients. This evidence concerns the gene GHRL and myeloid sarcoma.